Cargando…

A Case of Near-triploidy in Myelodysplastic Syndrome with del(5q) Combined with del(1p) and del(13q)

Numerical and structural chromosomal abnormalities are common in hematological malignancies. Near-triploidy (58-80 chromosomes) is a numerical abnormality observed in 3% of adult cases of acute lymphoblastic leukemia. Near-triploidy is rare in myeloid lineage hematologic malignancies and compared to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Bo-Ram, Kim, Ji-Eun, Woo, Kwang-Sook, Kim, Kyeong-Hee, Kim, Jeong-Man, Lee, Suee, Shaffer, Lisa G., Han, Jin-Yeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384812/ https://www.ncbi.nlm.nih.gov/pubmed/22779072 http://dx.doi.org/10.3343/alm.2012.32.4.294

Ejemplares similares

Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q)
por: Zhang, Rui, et al.
Publicado: (2015)

Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicity
por: Hong, Junshik, et al.
Publicado: (2021)

Van den Berghe's 5q- syndrome and myelodysplastic syndrome with isolated del(5q)
por: Lima, Diego Silva, et al.
Publicado: (2015)

Del(5q) myelodysplastic syndrome combined with pure red cell aplasia
por: Park, Joowon
Publicado: (2018)

Practical Strategies for Management of Lenalidomide-Associated Cytopenias in Myelodysplastic Syndromes With del(5q)
por: Kurtin, Sandra E., et al.
Publicado: (2017)

Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes
por: Drusbosky, Leylah M., et al.
Publicado: (2020)

Del(5q) and inv(3) in myelodysplastic syndrome: A rare case report
por: Liang, Hai-Ping, et al.
Publicado: (2022)

Clonal dominance of a donor‐derived del(20q) clone after allogeneic hematopoietic stem cell transplantation in an acute myeloid leukemia patient with del(20q)
por: Yoon, Jung, et al.
Publicado: (2019)

ZAP70 Expression Within del6q21, del11q13 and del17p13 Cytogenetic Subgroups of Iranian Patients with Chronic Lymphocytic Leukemia
por: Jafari Ghahfarokhi, Hamideh, et al.
Publicado: (2014)

Repeatability of QuantiFERON-TB Gold In-Tube Assay Results Near Cut-Off Points
por: Woo, Kwang-Sook, et al.
Publicado: (2016)

Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)
por: Butrym, Aleksandra, et al.
Publicado: (2015)

Images from the Haematologica Atlas of Hematologic Cytology: myelodysplastic syndrome with isolated del(5q)
por: Invernizzi, Rosangela
Publicado: (2022)

Myelodysplastic Syndromes with Isolated del(5q): Value of Molecular Alterations for Diagnostic and Prognostic Assessment
por: Acha, Pamela, et al.
Publicado: (2022)

CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q)
por: Bello, Erica, et al.
Publicado: (2015)

Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q)
por: Sekeres, M A, et al.
Publicado: (2014)

The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q)
por: Sekeres, Mikkael A., et al.
Publicado: (2018)

PB1912: MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION AND ASSOCIATED 5Q DELETION TO 13Q DELETION
por: Bouayed Abdelmoula, N., et al.
Publicado: (2022)

Chromosome 11q13 deletion syndrome
por: Kim, Yu-Seon, et al.
Publicado: (2016)

Complete Remission of del(5q) Myelodysplastic Syndrome after 7 Days of Lenalidomide Therapy Gives an Alert!
por: Al-Jafar, Hassan A., et al.
Publicado: (2012)

Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes
por: Komrokji, R. S., et al.
Publicado: (2016)

Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients
por: Santini, Valeria, et al.
Publicado: (2020)

Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell Approach
por: Acha, Pamela, et al.
Publicado: (2021)

TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes
por: McGraw, Kathy L., et al.
Publicado: (2015)

Successful Treatment of Concurrently Diagnosed Multiple Myeloma and Myelodysplastic Syndrome With Isolated Del(5q) With Lenalidomide, Bortezomib, and Dexamethasone
por: Washington, Nyomi R, et al.
Publicado: (2021)

Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
por: Gurnari, Carmelo, et al.
Publicado: (2022)

A case of myelodysplastic syndrome with a der(1;18)(q10;q10) translocation
por: Ha, Jung-Sook, et al.
Publicado: (2014)

FISH Analysis for del6q21 and del17p13 in B-cell Chronic Lymphocytic Leukemia in Iranians
por: Teimori, Hossein, et al.
Publicado: (2013)

Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes
por: Giagounidis, Aristoteles, et al.
Publicado: (2013)

Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
por: Scharenberg, Christian, et al.
Publicado: (2017)

S173: RETROSPECTIVE STUDY OF LENALIDOMIDE DISCONTINUATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME HARBORING DEL(5Q). A HARMONY ALLIANCE STUDY
por: Crisà, Elena, et al.
Publicado: (2023)

Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q)
por: Tefferi, Ayalew, et al.
Publicado: (2017)

A microdeletion del(12)(p11.21p11.23) with a cryptic unbalanced translocation t(7;12)(q21.13;q23.1) implicates new candidate loci for intellectual disability and Kallmann syndrome
por: Ben-Mahmoud, Afif, et al.
Publicado: (2023)

A cryptic microdeletion del(12)(p11.21p11.23) within an unbalanced translocation t(7;12)(q21.13;q23.1) implicates new candidate loci for intellectual disability and Kallmann syndrome
por: Ben-Mahmoud, Afif, et al.
Publicado: (2023)

Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation
por: Muto, Tomoya, et al.
Publicado: (2023)

A case of myelodysplastic syndrome with t(10;18)(q26;q21)
por: Ohba, Yusuke, et al.
Publicado: (2019)

Various endocrine disorders in children with t(13;14)(q10;q10) Robertsonian translocation
por: Choi, Byung Ho, et al.
Publicado: (2013)

Copy Number Gains at 8q24 and 20q11-q13 in Gastric Cancer Are More Common in Intestinal-Type than Diffuse-Type
por: Jin, Dong-Hao, et al.
Publicado: (2015)

Prenatal diagnosis of a 7q21.13q22.1 deletion detected using high-resolution microarray
por: Kim, Kyoung-Bo, et al.
Publicado: (2014)

Descriminación automática de cargas del sistema eléctrico del C.P.Q. Morelos
por: Sánchez Martínez, Miguel Angel
Publicado: (1999)

Triploidy—Observations in 154 Diandric Cases
por: Scholz, Nanna Brink, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mmamms8h2f2lc5rgdpjaguvkc3